Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | G6PD | P11413 | 4/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.77 |
| ▸ | GABRA1 | P14867 | 5/20 | 0.58 |
| ▸ | GABRB2 | P47870 | 5/20 | 0.58 |
| ▸ | GABRG2 | P18507 | 3/20 | 0.58 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.58 |
| ▸ | GABRA2 | P47869 | 3/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | GLA | P06280 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.54 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | SHBG | P04278 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrahydrocortisone SCHEMBL1332665 | 1.00 | G6PD (0.79) | G6PDCYP3A4GABRA1GABRB2GABRG2 | |
| Tetrahydrocortisone SCHEMBL4111245 | 1.00 | G6PD (0.79) | G6PDCYP3A4GABRA1GABRB2GABRG2 | |
| Tetrahydrocortisone SCHEMBL1184193 | 1.00 | G6PD (0.79) | G6PDCYP3A4GABRA1GABRB2GABRG2 | |
| Tetrahydrocortisone SCHEMBL5610354 | 1.00 | G6PD (0.79) | G6PDCYP3A4GABRA1GABRB2GABRG2 | |
| Tetrahydrocortisone SCHEMBL193711 | 1.00 | G6PD (0.79) | G6PDCYP3A4GABRA1GABRB2GABRG2 | |
| Tetrahydrocortisone SCHEMBL5139991 | 0.99 | G6PD (0.77) | G6PDCYP3A4GABRA1GABRB2GABRG2 | |
| Tetrahydrocortisone SCHEMBL8366487 | 0.99 | G6PD (0.77) | G6PDCYP3A4GABRA1GABRB2GABRG2 | |
| Tetrahydrocortisone SCHEMBL8360187 | 0.99 | G6PD (0.77) | G6PDCYP3A4GABRA1GABRB2GABRG2 | |
| Tetrahydrocortisone SCHEMBL11169159 | 0.99 | G6PD (0.77) | G6PDCYP3A4GABRA1GABRB2GABRG2 | |
| Tetrahydrocortisone SCHEMBL6461669 | 0.99 | G6PD (0.77) | G6PDCYP3A4GABRA1GABRB2GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115053935-A | Application of lactobacillus salivarius in breeding of litopenaeus vannamei larvae | 华南理工大学 | 2022-09-16 | — | — | CN | claimed |
| WO-2007044229-A2 | SURFACE TREATMENTS FOR CALCIUM PHOSPHATE-BASED IMPLANTS | CALCITEC, INC. (US) | 2007-04-19 | — | — | WO | claimed |
| EP-0778768-B1 | FORMULATIONS AND METHODS FOR PROVIDING PROLONGED LOCAL ANESTHESIA | EURO CELTIQUE SA (LU) | 2004-05-26 | — | — | EP | claimed |
| US-20030185873-A1 | Formulations and methods for providing prolonged local anesthesia | CHASIN MARK (US) | 2003-10-02 | — | — | US | claimed |
| US-6514516-B1 | Local anesthetic and a biocompatible controlled release material consisting of polyanhydrides, copolymers of lactic acid and glycolic acid, poly(lactic) acid, poly(glycolic) acid, polyesters, polyorthoesters, proteins, polysaccharides | EURO-CELTIQUE, S.A. (LU) | 2003-02-04 | — | — | US | claimed |
| EP-0778768-A4 | FORMULATIONS AND METHODS FOR PROVIDING PROLONGED LOCAL ANESTHESIA | EURO CELTIQUE SA (LU) | 2000-10-11 | — | — | EP | claimed |
| EP-0778768-A1 | FORMULATIONS AND METHODS FOR PROVIDING PROLONGED LOCAL ANESTHESIA | Euroceltique S.A. (LU) | 1997-06-18 | — | — | EP | claimed |
| WO-1996041616-A1 | FORMULATIONS AND METHODS FOR PROVIDING PROLONGED LOCAL ANESTHESIA | EURO-CELTIQUE, S.A. (LU) | 1996-12-27 | — | — | WO | claimed |
| WO-2025005885-A1 | CORTISOL SENSOR AND METHODS OF THEIR USE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2025-01-02 | — | — | WO | disclosed |
| CN-115053935-A | Application of lactobacillus salivarius in breeding of litopenaeus vannamei larvae | 华南理工大学 | 2022-09-16 | — | — | CN | disclosed |
| US-11419961-B2 | Bone induction system and methods | VIVEX BIOLOGICS GROUP, INC. (US) | 2022-08-23 | — | — | US | disclosed |
| US-20210212934-A1 | METHODS FOR PROVIDING LONG-LASTING ANESTHETIC EFFECT USING MICROPARTICLES | CAPSULATED SYSTEMS, INC. (US) | 2021-07-15 | — | — | US | disclosed |
| EP-2222284-B1 | PROLONGED RELEASE OF LOCAL ANESTHETICS USING MICROPARTICLES AND SURGERY APPLICATIONS | CAPSULATED SYSTEMS INC (US) | 2020-07-01 | — | — | EP | disclosed |
| US-20200085732-A1 | Prolonged Release of Local Anesthetics Using Microparticles and Surgery Applications | CAPSULATED SYSTEMS, INC. (US) | 2020-03-19 | — | — | US | disclosed |
| EP-1009390-A1 | PROLONGED ANESTHESIA IN JOINTS AND BODY SPACES | Euro-Celtique S.A. (LU) | 2000-06-21 | — | — | EP | disclosed |
| US-5942241-A | A SUSTAINED RELEASE DRUG CONTAINING A SUBSTRATE COMPRISING A LOCAL ANESTHETIC AND A BIOCOMPATIBLE, BIODEGRADABLE, CONTROLLED RELEASE POLYMER SELECTED FROM POLYANHYDRIDES, LACTIC ACID AND GLYCOLIC ACID HOMO-OR/AND COPOLYMERS | EURO-CELTIQUE, S.A. (LU) | 1999-08-24 | — | — | US | disclosed |
| WO-1999001114-A1 | PROLONGED ANESTHESIA IN JOINTS AND BODY SPACES | EURO-CELTIQUE, S.A. (LU) | 1999-01-14 | — | — | WO | disclosed |
| EP-0778768-A1 | FORMULATIONS AND METHODS FOR PROVIDING PROLONGED LOCAL ANESTHESIA | Euroceltique S.A. (LU) | 1997-06-18 | — | — | EP | disclosed |
| WO-1996041616-A1 | FORMULATIONS AND METHODS FOR PROVIDING PROLONGED LOCAL ANESTHESIA | EURO-CELTIQUE, S.A. (LU) | 1996-12-27 | — | — | WO | disclosed |
| WO-1995002424-A1 | LOCALIZATION AND THERAPY OF NON-PROSTATIC ENDOCRINE CANCER WITH AGENTS DIRECTED AGAINST PROSTATE SPECIFIC ANTIGEN | NORDION INTERNATIONAL INC. (CA) | 1995-01-26 | — | — | WO | disclosed |